ArticleJournal of gastroenterology2023

Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.

Dag Holmberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.